Titre:
  • Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results
Auteur:Lauritsen, K; Devière, Jacques; Bigard, M-A; Bayerdörffer, E; Mózsik, G; Murray, F; Kristjánsdóttir, S; Savarino, V; Vetvik, K; De Freitas, D; Orive, V; Rodrigo, L; Fried, M; Morris, J; Schneider, H; Eklund, S; Larkö, A
Informations sur la publication:Alimentary pharmacology & therapeutics, 17 Suppl 1, page (24; discussion 25-24; discussion 27)
Statut de publication:Publié, 2003-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:2-Pyridinylmethylsulfinylbenzimidazoles
Anti-Ulcer Agents -- administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Esophagitis, Peptic
Humans
Omeprazole -- administration & dosage
Omeprazole -- analogs & derivatives
Note générale:Clinical Trial
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
FLWIN
Langue:Anglais
Identificateurs:urn:issn:0269-2813
info:doi/10.1046/j.1365-2036.2003.01464.x
info:pii/200
info:pmid/12614304